DiaSorin Molecular LLC introduces three new primer pairs for use in laboratory-developed molecular tests.
DiaSorin Molecular LLC introduces three new primer pairs for use in laboratory-developed molecular tests. The reagents are specific to three bacterial targets – Anaplasma phagocytophilum, Ehrlichia and Babesia species. These bacteria are commonly carried by ticks. The new offerings join DiaSorin Molecular’s menu of more than 60 molecular reagents for bacterial, viral and fungal targets in addition to human genetic mutations. The primer pairs are classified as Analyte Specific Reagents (ASRs), which can be used by high-complexity laboratories to develop their own laboratory-developed tests (LDTs).
Tick-borne infections are on the rise, with reported cases more than doubling between 2004 and 2016. Factors behind the increase include a rise in human travel, which can result in the spread of tick-borne bacteria to new locations, climate and habitat changes affecting animals that harbor ticks.
“These new primer pairs are the result of our ongoing work to develop and deliver a robust menu of molecular products,” said Michelle Tabb, vice president of research and development for DiaSorin Molecular. “With greater access to commercially developed molecular reagents, diagnostic labs are better able to customize tests that meet their unique patient needs.”
About DiaSorin Molecular
DiaSorin Molecular LLC manufactures and distributes innovative molecular diagnostic products for hospital and reference laboratories. The company’s products help laboratories consolidate their testing, streamline processes and increase efficiency. DiaSorin Molecular’s Simplexa® molecular diagnostic kits are designed for use on the company’s versatile LIAISON® MDX platform. The company provides service and support solutions for its kits and instruments through a global network of offices and distributors. DiaSorin Molecular also markets a range of ASRs (Analyte Specific Reagents) for use in laboratory-developed tests.
